Biomarkers for Immuno-Oncology

Disease immunotherapy is the utilization of the safe framework to treat tumor. Immunotherapies can be ordered as dynamic, uninvolved or half and half. These methodologies abuse the way that growth cells frequently have atoms on their surface that can be distinguished by the resistant framework, known as tumor-related antigens, they are regularly proteins or different macromolecules (e.g. sugars).

Dynamic immunotherapy guides the resistant framework to assault tumor cells by focusing on TAAs. Latent immunotherapies upgrade existing against tumor reactions and incorporate the utilization of monoclonal antibodies, lymphocytes and cytokines.

  • Personalized Immunotherapy
  • Companion Diagnostics For Immunotherapy
  • Biomarkers to guide Immunotherapy
  • Clinical Trials for Cancer Immunotherapy

Related Conference of Biomarkers for Immuno-Oncology

Aug 21-22, 2017

World Medical Laboratory Congress & Expo

San Francisco, USA
September 21-22. 2017

3rd International Conference on Autism

Los Angeles, USA
October 18-20, 2017

10th World Congress on Biomarkers & Clinical Research

Baltimore, USA
November 13-15,2017

17th World Fitness Expo

(10 Plenary Forums - 1Event) Atlanta, USA
November 29-30, 2017

EuroSciCon Conference on Psychiatry

Madrid, Spain

Biomarkers for Immuno-Oncology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in